公司资料
BriaCell 股价、新闻与催化剂
- 股票代码:
- BCTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Canada
股票表现
3.39 USD (-1.45%)
收盘价
最后更新: 2026年8月17日
23.7M USD
市值
股价为何变动
As of Aug 17, 2026, BCTX closed down 1.45% at $3.39. No new same-company headline was identified in the current news window.
公司概览
业务概览
BriaCell is an immuno-oncology company focused on cancer vaccines and cellular immunotherapy. Its platform aims to create targeted immune responses against tumors.
所在地与行业分类
Headquartered in Canada and listed on NASDAQ, BriaCell has a cross-border cancer-biotech profile.
商业模式特征
The company depends on clinical data, immunotherapy differentiation, and the ability to create a niche oncology franchise.
生物医药行业定位
BriaCell is a high-beta immunotherapy name whose valuation is highly sensitive to early clinical updates.
未来催化剂
- BriaCell’s catalysts are Bria-IMT and its oncology immunotherapy platform, especially any readout that shows the company can keep advancing toward a viable clinical profile. The stock is driven by binary data.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。